NA Proactive news snapshot: LeanLife, WeedMD, Royal Road Minerals, Zynerba, Canada Silver Cobalt, The Flowr Corporation UPDATE ...

NA Proactive news snapshot: LeanLife, WeedMD, Royal Road Minerals, Zynerba, Canada Silver Cobalt, The Flowr Corporation UPDATE ...

Proactive Investors

Published

LeanLife Health Inc (CSE:LLP) (FSE:LL1) (OTCPINK:LNLHF) announced Thursday that it will be ordering several additional containers of Mike Tyson branded Iron Energy drink thanks to strong demand from US retailers. The products will be shipped from LeanLife’s Polish partner FoodCare Group, which is the global manufacturer of Mike Tyson branded energy drinks. Leanlife noted that these containers are in addition to the containers that have already shipped and are due to arrive by end of January in Arizona. In a statement, CEO Stan Lis said that since Tyson's widely watched comeback fight last month in Los Angeles, the profile of the legendary boxer and the Iron Energy drink has grown even stronger. “I anticipate being able to sell more than 100 containers of Iron Energy in 2021 based on initial demand," Lis said. WeedMD Inc (CVE:WMD) (OTCQX:WDDMF) (FRA:4WE) reported that it has launched its new one-gram, 510-thread vaporization (vape) products in Ontario, expanding the company’s Cannabis 2.0 product portfolio. WeedMD’s terpene-infused vapes, which includes flavoured strains such as Lemon Haze and Sour Pineapple, will be sold under WeedMD’s Saturday Cannabis branded line-up and is expected to be available to consumers via the Ontario Cannabis Store (OCS) by the end of December 2020. Royal Road Minerals Limited (CVE:RYR) (OTCMKTS:RRDMF) (FRA:RLU) announced that it has entered into a binding Letter of Intent (LOI) to sell its entire 50% stake in the Luna Roja gold project in Nicaragua to Mineros S.A. Royal Road Minerals is expected to receive US$22.5 million in cash payable on closing, for its 50% interest in the project, plus a 1.25% net smelter royalty on all future mineral production from the Monte Carmelo I and Monte Carmelo II mining concessions. Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) (FRA:6ZY) on Thursday provided an update on its meeting with the US Food and Drug Administration regarding its Fragile X syndrome (FXS) program using Zygel, a patent-protected CBD skin gel. The company plans to conduct a double-blind, placebo-controlled pivotal trial in patients with FXS, who have a highly methylated FMR1 gene to confirm the positive results observed in this population of responders in the CONNECT-FX trial. In the first half of 2021, Zynerba said it will review the trial design and protocol for the new trial through a Type C meeting with the FDA and expects to initiate the pivotal trial before the end of 2021. Zynerba said it believes that positive results from this confirmatory trial would be sufficient to support the submission of a New Drug Application (NDA) for Zygel in FXS. Canada Silver Cobalt Works (CVE:CCW) (OTCQB:CCWOF) (FRA:4T9B) reported a further boost for its Castle property in Ontario on Thursday, revealing it had uncovered high-grade gold mineralization with cobalt within the mineralized vein structures at the asset. The company is focused on the Gowganda district - one of the few places globally where silver and cobalt can be mined together - and has completed 18,000 metres (m) of drilling of a 50,000m program. Two rigs are turning. Highlight assays included 24.95 grams per ton (g/t) of gold over 0.30 meters from 49.70 to 50.00m depth in one hole. The same hole also hit 3.82 g/t of gold over 2.86 meters from 451m to 453.86m, including 6.11 g/t of the yellow metal over 1.66 meters from 451.52m to 453.18m. The Flowr Corporation (CVE:FLWR) (OTCMKTS:FLWPF) announced harvest results from its Portugal operations, as well as a strategic warehousing agreement with Tilray Inc (NASDAQ:TLRY) in order to advance both companies' cannabis businesses in the European Union. The company said Tilray will store its medical cannabis at Flowr Corp’s Sintra facility in Portugal before shipping its product for sale in the European market. Commercial terms of the agreement were not disclosed. Melkior Resources Inc (CVE:MKR) (OTCMKTS:MKRIF) (FRA:MEK1) said it will begin a drill program at its Maseres property in the Urban-Barry camp, Quebec in early January next year before drilling its Val d’Or East project. It comes after the group reevaluated data following a till survey completed at Maseres during the summer, which have indicated a possible source of mineralization just up-ice from previously drilled locations. This year's work saw 108 soil samples collected, including 70 samples on the A Block, 13 samples on the B Block, and 33 on the E Block. FansUnite Entertainment Inc (CSE:FANS) (OTCQB:FUNFF) announced Thursday that an upsized private placement to raise $11 million for working capital and general corporate purposes. Due to strong investor demand, the Vancouver-based company said it will offer for sale up to 17,600,000 special warrants at $0.625 each. The company has also amended the option grant to Gravitas Securities Inc, as sole agent and bookrunner, for the sale of up to an additional 2,640,000 special warrants, which is exercisable in whole or in part at any time up to 30 days following the closing of the offering. The initial closing date is expected to be on or about the week of January 11th, 2021 and the offering may be completed in one or more closings at the discretion of the lead agent. Pacton Gold Inc (CVE:PAC) (OTCPINK:PACXF) (FRA:2NKM) said it had closed an oversubscribed financing, bringing in more than C$3.6 million. In a statement, the explorer said that 2.01 million flow-through (FT) shares were issued at $1 per FT Share for total gross proceeds of C$2.01 million, while its private placement of around 1.8 million shares at C$0.90 each raised C$1.627 million gross. Silvercorp Metals Inc (TSE:SVM) (NYSEAMERICAN:SVM) revealed it had published its first sustainability report, prepared in accordance with the Global Reporting Initiative (GRI) Standards: Core Option as a guide, which provides information on the miner's governance, safety, environmental, and social performance. "One of Silvercorp’s key principles is to be a good corporate citizen and accountable to all its stakeholders," said Dr. Rui Feng, the company's CEO and chairman. "As a result, the company has implemented numerous programs over the years to ensure it operates in a responsible manner with respect to employee and contractor safety, environmental protection and community relations. This sustainability report, Silvercorp’s first, allows us to highlight our actions as well as our commitment to communicate on these topics on an ongoing basis." Fury Gold Mines Limited (TSE:FURY) (NYSEAMERICAN:FURY) (FRA:AUN1) told investors it has identified two significant gold-in-till targets at the Éléonore South joint venture (ESJV), which it aims to advance towards drilling in the summer of next year. The ESJV in Quebec was formed in 2008 and Fury is the operator on behalf of its partners. It holds a 36.72% stake, while Azimut Exploration holds 26.57%. Les Mines Opinaca Ltée, which is a wholly-owned subsidiary of Newmont, holds 36.71% of the venture. XPhyto Therapeutics Corp (CSE:XPHY) (OTCQB:XPHYF (FSE:4XT) and its exclusive German diagnostics development partner 3a-diagnostics GmbH announced the successful validation of their point-of-care SARS-CoV-2 (COVID-19) RT-PCR test system.  In addition, XPhyto said European regulatory approval and commercial product launch in European markets are planned for the first quarter of 2021. The newly developed test system has demonstrated diagnostic level accuracy (sensitivity and specificity) in its ability to detect SARS-CoV-2 RNA within 25 minutes. Robustness, repeatability, and laboratory precision have also been confirmed. The test is designed to be conducted with only minimal laboratory processes and equipment. O3 Mining Inc (CVE:OIII) (OTCMKTS:OQMGF) reported Thursday a "spectacular" drill intercept from its Simkar zone within the Sector 3 of its Alpha property in Québec. The hole was sunk at the western extension of the Simkar zone and included an assay of 413 grams per ton (g/t) gold over 1.2 metres (m). Immediate follow-up drilling of this intercept is underway."This is a spectacular intercept and one which is associated with a well-developed structure and is flanked by two significant previous drill intercepts 200 metres away on each side," noted chief executive of O3 Jose Vizquerra. "With all of these holes about 600 metres from the historical mine, it strongly suggests the presence of an important ore shoot in the down-plunge extension of the Simkar. Our winter drilling program will continue targeting this area and so we look forward to receiving more results early in the new year." Humanigen Inc (NASDAQ:HGEN) (FRA:0KB2) has completed patient enrollment in its Phase 1 bioimaging study of ifabotuzumab to treat recurrent brain cancer -  glioblastoma multiforme (GBM). The primary goal of this Phase 1 trial is to evaluate the safety of ifabotuzumab and to recommend a dose for a potential Phase 2 study, either with ifabotuzumab or an antibody drug conjugate (ADC) based on ifabotuzumab. Humanigen's trial is located at the Olivia Newton-John Cancer Research Institute in Victoria, Australia and results are expected in the first half of 2021. Great Panther Mining Limited (TSE:GPR) (NYSEAMERICAN:GPL) (FRA:G3U) reported that it has re-started mining activities at its Topia silver and gold mine in Mexico following a voluntary suspension of operations last month due to COVID-19 health and safety concerns. The company noted that the suspension of operations lasted about 30 days and is not expected to impact its ability to achieve consolidated 2020 production guidance.  BevCanna Enterprises Inc (CSE:BEV) (QTCQB:BVNNF) (FRA:7BC) announced Thursday that its acquisition of Naturo Group Investments Inc will close on or before January 20, 2021. In a statement, BevCanna said the merger will create a comprehensive health and wellness beverage and natural products company, one that generates significant value for both organizations and brings together two exceptionally experienced and innovative leadership teams. Vancouver-based BevCanna said it will catapult the company into the unique position of becoming the only fully licensed, in-house, and white-label beverage manufacturing company that distributes both conventional and cannabis-based beverage and wellness products. The merger will provide it access to global, multi-channel distribution networks of traditional and cannabis sales channels. Falcon Gold Corp (CVE:FG) (OTCPINK:FGLDF) (FRA:3FA) said it had received conditional acceptance for its previously announced C$750,000 private placing from the TSX venture exchange to fund continued exploration on its existing properties, outstanding payables and general working capital. Units are priced at C$0.12 and comprise one Falcon share and one non-transferable warrant. Each warrant entitles the holder to buy a new share for C$0.20 for 36 months. Shares and warrants are subject to a four-month hold period. Algernon Pharmaceuticals Inc (CSE:AGN) (OTCQB:AGNPF) revealed that its chief executive Christopher J. Moreau and chief science officer Dr Mark Williams, will be discussing interim data on the company's Phase 2b/3 clinical study of Ifenprodil for COVID-19 on an upcoming free BioPub webcast on December 17 that will be hosted by Dr. KSS at noon ET. The company invites interested shareholders, investors, members of the media and the public to listen. To join the webinar, please click HERE. https://us02web.zoom.us/j/83294585006    

Full Article